Metraipolis › archive › dc_5e90b657d48e
Targeting highly attenuated IL-18 to PD-1 for enhanced anti-tumor activity — Europe PMC PMID:41488627
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41488627
- DOI
- 10.3389/fimmu.2025.1718321
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T13:11:16.299Z
- SHA-256 of the archived text
442a73fc1b0d511f9905b6572671124f0d9f457234b74e6c30d90ab5f473c93f- Stable URL of this page
https://metraipolis.com/documento/dc_5e90b657d48e
How to cite
Targeting highly attenuated IL-18 to PD-1 for enhanced anti-tumor activity — Europe PMC PMID:41488627 — Europe PMC (en), https://europepmc.org/article/MED/41488627 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5e90b657d48e (Metraipolis archive dc_5e90b657d48e, sha256 442a73fc1b0d511f9905b6572671124f0d9f457234b74e6c30d90ab5f473c93f)
BibTeX
@misc{dc5e90b657d48e,
title = {Targeting highly attenuated IL-18 to PD-1 for enhanced anti-tumor activity — Europe PMC PMID:41488627},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41488627},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5e90b657d48e; sha256 442a73fc1b0d511f9905b6572671124f0d9f457234b74e6c30d90ab5f473c93f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41488627. Agents can read the archived copy with the MCP tool read_document.